IMMUNOVANT

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Its investigational product candidate, IMVT-1401 (formerly known as RVT-1401), is a novel, fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn). We believe that this product has the potential to address a variety of IgG-mediated autoimmune diseases as a subcutaneous injection.

#SimilarOrganizations #People #Financial #Event #Website #More

IMMUNOVANT

Social Links:

Industry:

Biotechnology Pharmaceutical

Founded:

2018-01-01

Address:

New York, New York, United States

Country:

United States

Website Url:

http://www.immunovant.com

Total Employee:

101+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

200 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Microsoft Exchange Online Amazon

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

pete-salzmann_image

Pete Salzmann
Pete Salzmann CEO @ Immunovant
CEO
2019-06-01

ron-bates_image

Ron Bates
Ron Bates VP, CMC Process Development and Technical Operations @ Immunovant
VP, CMC Process Development and Technical Operations
2020-10-01

not_available_image

Mark Levine
Mark Levine Chief Legal Officer and Corporate Secretary @ Immunovant
Chief Legal Officer and Corporate Secretary
2022-01-01

renee-barnett_image

Renee Barnett
Renee Barnett CFO @ Immunovant
CFO
2021-01-01

Stock Details

Company's stock symbol is NASDAQ:IMVT

Investors List

roivant-sciences_image

Roivant Sciences

Roivant Sciences investment in Post-IPO Equity - Immunovant

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - Immunovant

Key Employee Changes

Date	New article
2022-01-25	Immunovant Appoints Mark Levine as Chief Legal Officer
2021-09-15	Immunovant Appoints Renee Barnett as Chief Financial Officer

Official Site Inspections

http://www.immunovant.com Semrush global rank: 852.69 K Semrush visits lastest month: 44.46 K

Host Informations
Whois Informations

Loading ...

More informations about "Immunovant" on Search Engine